| Year |
Title |
Altmetric |
| 2019
|
Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.
International Journal of Cardiology.
286:145-151.
2019
|
|
| 2019
|
Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults.
JACC: Heart Failure.
7:394-401.
2019
|
|
| 2019
|
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART.
Journal of Acquired Immune Deficiency Syndromes.
81.
2019
|
|
| 2019
|
Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.
Journal of the American College of Cardiology.
73:2036-2045.
2019
|
|
| 2019
|
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.
American Journal of Kidney Diseases.
73:206-217.
2019
|
|
| 2019
|
A PheWAS study of a large observational epidemiological cohort of African Americans from the REGARDS study.
BMC Medical Genomics.
12.
2019
|
|
| 2019
|
Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium.
BMJ.
364.
2019
|
|
| 2018
|
Adherence to Mediterranean-style diet and risk of sepsis in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.
British Journal of Nutrition.
120:1415-1421.
2018
|
|
| 2018
|
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
American Journal of Kidney Diseases.
72:834-845.
2018
|
|
| 2018
|
Serum albumin concentration and risk of end-stage renal disease: The REGARDS study.
Nephrology Dialysis Transplantation.
33:1770-1777.
2018
|
|
| 2018
|
Plasma 25-hydroxyvitamin D and the Longitudinal Risk of Sepsis in the REGARDS Cohort..
Clinical Infectious Diseases.
2018
|
|
| 2018
|
Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.
American Journal of Kidney Diseases.
72:419-428.
2018
|
|
| 2018
|
Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.
American Journal of Kidney Diseases.
72:205-213.
2018
|
|
| 2018
|
FGF23 (fibroblast growth factor-23) and incident hypertension in young and middle-aged adults: The CARDIA study.
Hypertension.
72:70-76.
2018
|
|
| 2018
|
Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders.
Nephrology Dialysis Transplantation.
33:986-992.
2018
|
|
| 2018
|
Dietary Oxidative Balance Scores and Biomarkers of Inflammation among Individuals with and without Chronic Kidney Disease.
Nephron Extra.
8:11-23.
2018
|
|
| 2018
|
Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.
American Journal of Nephrology.
47:242-250.
2018
|
|
| 2018
|
Association of fibroblast growth factor 23 with risk of incident coronary heart disease in community-living adults.
JAMA Cardiology.
3:318-325.
2018
|
|
| 2018
|
APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults.
Kidney International.
93:727-732.
2018
|
|
| 2018
|
Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: A randomized controlled trial.
BMC Nephrology.
19.
2018
|
|
| 2018
|
Racial differences in plasma levels of n-Terminal pro-b-Type natriuretic peptide and outcomes the reasons for geographic and racial differences in stroke (regards) study.
JAMA Cardiology.
3:11-17.
2018
|
|
| 2017
|
Association between APOL1 genotypes and risk of cardiovascular disease in MESA (Multi-Ethnic Study of Atherosclerosis).
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.
6.
2017
|
|
| 2017
|
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD).
American Journal of Kidney Diseases.
70:737-751.
2017
|
|
| 2017
|
APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.
Kidney International.
92:964-971.
2017
|
|
| 2017
|
Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial.
American Journal of Transplantation.
17:2640-2649.
2017
|
|
| 2017
|
Global cardiovascular and renal outcomes of reduced GFR.
Journal of the American Society of Nephrology.
28:2167-2179.
2017
|
|
| 2017
|
Sickle cell trait and the risk of ESRD in blacks.
Journal of the American Society of Nephrology.
28:2180-2187.
2017
|
|
| 2017
|
Association between soluble klotho and change in kidney function: The health aging and body composition study.
Journal of the American Society of Nephrology.
28:1859-1866.
2017
|
|
| 2017
|
Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease.
American Journal of Nephrology.
45:338-345.
2017
|
|
| 2017
|
BP control and long-term risk of ESRD and mortality.
Journal of the American Society of Nephrology.
28:671-677.
2017
|
|
| 2017
|
Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Heart Rhythm.
14:65-71.
2017
|
|
| 2017
|
Association of urinary uromodulin with kidney function decline and mortality: The health ABC study.
Clinical Nephrology.
87:278-286.
2017
|
|
| 2016
|
Response by Gutiérrez et al to letter regarding article, "Hemoglobin concentration and risk of incident stroke in community-living adults".
Stroke.
47:e260.
2016
|
|
| 2016
|
Vitamin D, Fibroblast growth factor 23 and incident cognitive impairment: Findings from the REGARDS study.
PLoS ONE.
11.
2016
|
|
| 2016
|
Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults.
Journal of Clinical and Translational Endocrinology.
5:21-25.
2016
|
|
| 2016
|
Associations of blood pressure, sunlight, and Vitamin D in community-dwelling adults.
Journal of Hypertension.
34:1704-1710.
2016
|
|
| 2016
|
Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults.
Stroke.
47:2017-2024.
2016
|
|
| 2016
|
Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy.
Nephrology Dialysis Transplantation.
31:1031-1033.
2016
|
|
| 2016
|
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.
Seminars in Nephrology.
36:252-261.
2016
|
|
| 2016
|
Admixture mapping of serum vitamin D and parathyroid hormone concentrations in the African American-Diabetes Heart Study.
BONE.
87:71-77.
2016
|
|
| 2016
|
Fibroblast growth factor 23 and heart failure: The plot thickens.
Nephrology Dialysis Transplantation.
31:688-690.
2016
|
|
| 2016
|
Genetic african ancestry and markers of mineral metabolism in CKD.
Clinical Journal of the American Society of Nephrology.
11:653-662.
2016
|
|
| 2016
|
APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Nephrology Dialysis Transplantation.
31:602-608.
2016
|
|
| 2016
|
The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old.
Archives of Medical Science.
12:55-67.
2016
|
|
| 2016
|
Association of reduced eGFR and albuminuria with serious fall injuries among older adults.
Clinical Journal of the American Society of Nephrology.
11:1236-1243.
2016
|
|
| 2016
|
Vitamin D deficiency and incident stroke risk in community-living black and white adults.
International Journal of Stroke.
11:93-102.
2016
|
|
| 2016
|
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.
American Journal of Kidney Diseases.
67:62-69.
2016
|
|
| 2015
|
Oxidative Balance Score and Chronic Kidney Disease.
American Journal of Nephrology.
42:320-327.
2015
|
|
| 2015
|
Impact of phosphorus-based food additives on bone and mineral metabolism.
Journal of Clinical Endocrinology and Metabolism.
100:4264-4271.
2015
|
|
| 2015
|
Validation of an albuminuria self-assessment tool in the Multi-Ethnic Study of Atherosclerosis (MESA).
Ethnicity and Disease.
25:427-434.
2015
|
|
| 2015
|
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data.
Lancet Diabetes and Endocrinology.
3:514-525.
2015
|
|
| 2015
|
Diet patterns and risk of sepsis in community-dwelling adults: A cohort study.
BMC Infectious Diseases.
15.
2015
|
|
| 2015
|
Obesity, metabolic health, and the risk of end-stage renal disease.
Kidney International.
87:1216-1222.
2015
|
|
| 2015
|
APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.
BMC Genomics.
16.
2015
|
|
| 2015
|
Cystatin C and long term risk of community-acquired sepsis: A population-based cohort study.
BMC Nephrology.
1-10.
2015
|
|
| 2015
|
Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.
PLoS ONE.
10.
2015
|
|
| 2015
|
Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
Stroke.
46:322-328.
2015
|
|
| 2015
|
Bone mineral content as a driver of energy expenditure in prepubertal and early pubertal boys.
Journal of Pediatrics.
166:1397-1403.
2015
|
|
| 2015
|
Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals.
Journal of Clinical and Translational Endocrinology.
2:77-82.
2015
|
|
| 2015
|
Contextual poverty, nutrition, and chronic kidney disease.
Advances in Renal Replacement Therapy.
22:31-38.
2015
|
|
| 2015
|
Contrasting cholesterol management guidelines for adults with CKD.
Journal of the American Society of Nephrology.
26:1173-1180.
2015
|
|
| 2015
|
Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females.
Clinical Endocrinology.
82:550-556.
2015
|
|
| 2015
|
Prehospitalization risk factors for acute kidney injury during hospitalization for serious infections in the REGARDS cohort.
Nephron Extra.
5:87-99.
2015
|
|
| 2015
|
Response to Letter Regarding Article, "fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults".
Stroke.
46:e124.
2015
|
|
| 2015
|
Validation study of medicare claims to identify older US adults with CKD using the reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
65:249-258.
2015
|
|
| 2014
|
Reply to MF McCarty.
American Journal of Clinical Nutrition.
99:966-967.
2014
|
|
| 2014
|
High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III1-3.
American Journal of Clinical Nutrition.
99:320-327.
2014
|
|
| 2014
|
Contribution of Food Additives to Sodium and Phosphorus Content of Diets Rich in Processed Foods.
Journal of Renal Nutrition.
24.
2014
|
|
| 2014
|
Dietary patterns and risk of death and progression to ESRD in individuals with CKD: A cohort study.
American Journal of Kidney Diseases.
64:204-213.
2014
|
|
| 2014
|
Incident ESRD and treatment-resistant hypertension: The reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
63:781-788.
2014
|
|
| 2014
|
Low income, community poverty and risk of end stage renal disease.
BMC Nephrology.
15.
2014
|
|
| 2014
|
N-terminal pro-B-type natriuretic peptide and stroke risk: The reasons for geographic and racial differences in stroke cohort.
Stroke.
45:1646-1650.
2014
|
|
| 2014
|
Nondisease-specific problems and all-cause mortality among older adults with CKD: The REGARDS study.
Clinical Journal of the American Society of Nephrology.
9:1737-1745.
2014
|
|
| 2014
|
The association between race and income on riskof mortality in patients with moderate chronic kidney disease.
BMC Nephrology.
15.
2014
|
|
| 2013
|
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.
Clinical Journal of the American Society of Nephrology.
8:2064-2071.
2013
|
|
| 2013
|
Dietary patterns are associated with incident stroke and contribute to excess risk of stroke in black americans.
Stroke.
44:3305-3311.
2013
|
|
| 2013
|
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
Clinical Journal of the American Society of Nephrology.
8:1583-1590.
2013
|
|
| 2013
|
Chronic Kidney Disease in African Americans: Past, Present, and Future: Introduction.
Seminars in Nephrology.
33:407-408.
2013
|
|
| 2013
|
Fibroblast growth factor 23, vitamin d, and health disparities among african americans with chronic kidney disease.
Seminars in Nephrology.
33:448-456.
2013
|
|
| 2013
|
Association between urinary albumin excretion and coronary heart disease in black vs white adults.
Journal of the American Medical Association.
310:706-713.
2013
|
|
| 2013
|
Cardiovascular risk factors in CKD associate with both ESRD and mortality.
Journal of the American Society of Nephrology.
24:1159-1165.
2013
|
|
| 2013
|
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
Clinical Journal of the American Society of Nephrology.
8:1009-1018.
2013
|
|
| 2013
|
α-Klotho and kidney function decline: An important step forward in understanding the link between mineral metabolism and kidney disease progression.
American Journal of Kidney Diseases.
61:855-857.
2013
|
|
| 2013
|
Fibroblast Growth Factor 23, Klotho, and Disordered Mineral Metabolism in Chronic Kidney Disease: Unraveling the Intricate Tapestry of Events and Implications for Therapy.
Journal of Renal Nutrition.
23:250-254.
2013
|
|
| 2013
|
Geographic variation in CKD prevalence and ESRD incidence in the united states: Results from the reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
61:395-403.
2013
|
|
| 2013
|
Healthy behaviors, risk factor control and awareness of chronic kidney disease.
American Journal of Nephrology.
37:135-143.
2013
|
|
| 2013
|
Sodium- and Phosphorus-Based Food Additives: Persistent but Surmountable Hurdles in the Management of Nutrition in Chronic Kidney Disease.
Advances in Renal Replacement Therapy.
20:150-156.
2013
|
|
| 2013
|
Associations of Dietary Phosphorus Intake, Urinary Phosphate Excretion, and Fibroblast Growth Factor 23 With Vascular Stiffness in Chronic Kidney Disease.
Journal of Renal Nutrition.
23:12-20.
2013
|
|
| 2013
|
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
American Journal of Kidney Diseases.
61:67-73.
2013
|
|
| 2013
|
Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers.
American Heart Journal.
166.
2013
|
|
| 2013
|
The connection between dietary phosphorus, cardiovascular disease, and mortality: Where we stand and what we need to know.
Advances in Nutrition.
4:723-729.
2013
|
|
| 2012
|
Racial differences in albuminuria, kidney function, and risk of stroke.
Neurology.
79:1686-1692.
2012
|
|
| 2012
|
Statement of concern about a commercial assay used to measure soluble hemojuvelin in humans.
American Journal of Nephrology.
36:332-333.
2012
|
|
| 2012
|
Associations of Socioeconomic Status and Processed Food Intake With Serum Phosphorus Concentration in Community-Living Adults: The Multi-Ethnic Study of Atherosclerosis (MESA).
Journal of Renal Nutrition.
22:480-489.
2012
|
|
| 2012
|
High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: A pilot, randomized, double-blind, placebo-controlled trial.
American Journal of Clinical Nutrition.
96:672-679.
2012
|
|
| 2012
|
Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease.
Nephrology Dialysis Transplantation.
27:3482-3488.
2012
|
|
| 2012
|
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.
American Journal of Hypertension.
25:789-796.
2012
|
|
| 2012
|
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients.
Diabetes Research and Clinical Practice.
97:71-76.
2012
|
|
| 2012
|
Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.
Diabetes Care.
35:994-1001.
2012
|
|
| 2012
|
(1-34) parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.
Clinical Journal of the American Society of Nephrology.
7:139-145.
2012
|
|
| 2011
|
Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications.
Clinical Journal of the American Society of Nephrology.
6:2822-2828.
2011
|
|
| 2011
|
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.
Clinical Journal of the American Society of Nephrology.
6:2871-2878.
2011
|
|
| 2011
|
Recent insights into racial differences in bone and mineral metabolism.
Current Opinion in Endocrinology and Diabetes.
18:347-351.
2011
|
|
| 2011
|
FGF23 induces left ventricular hypertrophy.
Journal of Clinical Investigation.
121:4393-4408.
2011
|
|
| 2011
|
Hepcidin and disordered mineral metabolism in chronic kidney disease.
Clinical Nephrology.
76:90-98.
2011
|
|
| 2011
|
Vitamin D Deficiency, Inflammation, and Albuminuria in Chronic Kidney Disease: Complex Interactions.
Journal of Renal Nutrition.
21:295-302.
2011
|
|
| 2011
|
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
Journal of the American Medical Association.
305:2432-2439.
2011
|
|
| 2011
|
Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey.
Osteoporosis International.
22:1745-1753.
2011
|
|
| 2011
|
Increased serum phosphate and adverse clinical outcomes: Unraveling mechanisms of disease.
Current Opinion in Nephrology and Hypertension.
20:224-228.
2011
|
|
| 2011
|
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
Nephrology Dialysis Transplantation.
26:1258-1265.
2011
|
|
| 2011
|
Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey.
Journal of Renal Nutrition.
21:140-148.
2011
|
|
| 2011
|
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.
Nephrology Dialysis Transplantation.
26:584-591.
2011
|
|
| 2011
|
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
Kidney International.
79:1370-1378.
2011
|
|
| 2010
|
Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.
Nephrology Dialysis Transplantation.
25:3970-3977.
2010
|
|
| 2010
|
Low socioeconomic status associates with higher serum phosphate irrespective of race.
Journal of the American Society of Nephrology.
21:1953-1960.
2010
|
|
| 2010
|
Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: Updating the "trade-off" hypothesis.
Clinical Journal of the American Society of Nephrology.
5:1710-1716.
2010
|
|
| 2010
|
Dietary phosphorus restriction in advanced chronic kidney disease: Merits, challenges, and emerging strategies.
Seminars in Dialysis.
23:401-406.
2010
|
|
| 2010
|
Vitamin D deficiency and anemia in early chronic kidney disease.
Kidney International.
77:715-720.
2010
|
|
| 2010
|
Response to Targeting hyperphosphatemia: Truth or dare.
Kidney International.
77:257.
2010
|
|
| 2010
|
The authors reply.
Kidney International.
77:743-744.
2010
|
|
| 2010
|
The authors reply.
Kidney International.
77:930.
2010
|
|
| 2009
|
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease.
Kidney International.
76:705-716.
2009
|
|
| 2009
|
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
Circulation.
119:2545-2552.
2009
|
|
| 2009
|
Plasma gelsolin and circulating actin correlate with hemodialysis mortality.
Journal of the American Society of Nephrology.
20:1140-1148.
2009
|
|
| 2009
|
Phosphorus binders and survival on hemodialysis.
Journal of the American Society of Nephrology.
20:388-396.
2009
|
|
| 2008
|
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
New England Journal of Medicine.
359:584-592.
2008
|
|
| 2008
|
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: Prognostic value of baseline and follow-up measurements.
Clinical Chemistry.
54:1339-1348.
2008
|
|
| 2008
|
Impact of activated vitamin D and race on survival among hemodialysis patients.
Journal of the American Society of Nephrology.
19:1379-1388.
2008
|
|
| 2008
|
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.
Journal of the American Society of Nephrology.
19:615-623.
2008
|
|
| 2008
|
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.
Kidney International.
73:956-962.
2008
|
|
| 2007
|
Vitamin D levels and early mortality among incident hemodialysis patients.
Kidney International.
72:1004-1013.
2007
|
|
| 2007
|
Emphysematous pyelonephritis.
Kidney International.
71:462-465.
2007
|
|
| 2007
|
Refractory hyponatremia.
Kidney International.
71:79-82.
2007
|
|
| 2006
|
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?.
Kidney International.
70:1486-1494.
2006
|
|
| 2005
|
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Journal of the American Society of Nephrology.
16:2205-2215.
2005
|
|
| 1999
|
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly- arthropathy-coxa vara-pericarditis syndrome.
Nature Genetics.
23:319-322.
1999
|
|
